These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Carisoprodol: update on abuse potential and legal status. Reeves RR; Burke RS; Kose S South Med J; 2012 Nov; 105(11):619-23. PubMed ID: 23128807 [TBL] [Abstract][Full Text] [Related]
5. Assessment of direct gating and allosteric modulatory effects of meprobamate in recombinant GABA(A) receptors. Kumar M; Dillon GH Eur J Pharmacol; 2016 Mar; 775():149-58. PubMed ID: 26872987 [TBL] [Abstract][Full Text] [Related]
6. Impairment due to intake of carisoprodol. Bramness JG; Skurtveit S; Mørland J Drug Alcohol Depend; 2004 Jun; 74(3):311-8. PubMed ID: 15194209 [TBL] [Abstract][Full Text] [Related]
8. Flumazenil reversal of carisoprodol (Soma) intoxication. Roberge RJ; Lin E; Krenzelok EP J Emerg Med; 2000 Jan; 18(1):61-4. PubMed ID: 10645840 [TBL] [Abstract][Full Text] [Related]
9. Is the frequency of carisoprodol withdrawal syndrome increasing? Reeves RR; Hammer JS; Pendarvis RO Pharmacotherapy; 2007 Oct; 27(10):1462-6. PubMed ID: 17896902 [TBL] [Abstract][Full Text] [Related]
10. Carisoprodol pharmacokinetics and distribution in the nucleus accumbens correlates with behavioral effects in rats independent from its metabolism to meprobamate. Carbonaro TM; Nguyen V; Forster MJ; Gatch MB; Prokai L Neuropharmacology; 2020 Sep; 174():108152. PubMed ID: 32479814 [TBL] [Abstract][Full Text] [Related]
11. Carisoprodol - Effects on Human Performance and Behavior. Robertson MM; Marinetti LJ Forensic Sci Rev; 2003 Jan; 15(1):1-9. PubMed ID: 26256591 [TBL] [Abstract][Full Text] [Related]
12. Carisoprodol: a drug of continuing abuse. Reeves RR; Pinkofsky HB; Carter OS J Am Osteopath Assoc; 1997 Dec; 97(12):723-4. PubMed ID: 9439144 [TBL] [Abstract][Full Text] [Related]
13. Postmortem carisoprodol and meprobamate concentrations in blood and liver: lack of significant redistribution. McIntyre IM; Sherrard J; Lucas J J Anal Toxicol; 2012 Apr; 36(3):177-81. PubMed ID: 22417833 [TBL] [Abstract][Full Text] [Related]
14. A case report of carisoprodol dependence. Venugopal D; Deepak G; Murali N; Kumar KB; Sharma PS Indian J Psychiatry; 2000 Apr; 42(2):211-3. PubMed ID: 21407939 [TBL] [Abstract][Full Text] [Related]
15. Carisoprodol withdrawal after internet purchase. Eleid MF; Krahn LE; Agrwal N; Goodman BP Neurologist; 2010 Jul; 16(4):262-4. PubMed ID: 20592570 [TBL] [Abstract][Full Text] [Related]
16. Assessment of subunit-dependent direct gating and allosteric modulatory effects of carisoprodol at GABA(A) receptors. Kumar M; González LA; Dillon GH Neuropharmacology; 2015 Oct; 97():414-25. PubMed ID: 25896767 [TBL] [Abstract][Full Text] [Related]
17. Carisoprodol (Soma): a new and cautious perspective on an old agent. Littrell RA; Hayes LR; Stillner V South Med J; 1993 Jul; 86(7):753-6. PubMed ID: 8322081 [TBL] [Abstract][Full Text] [Related]
18. Carisoprodol, meprobamate, and driving impairment. Logan BK; Case GA; Gordon AM J Forensic Sci; 2000 May; 45(3):619-23. PubMed ID: 10855968 [TBL] [Abstract][Full Text] [Related]
19. Quantitation of Carisoprodol and Meprobamate in Urine and Plasma Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS). Slawson MH; Johnson-Davis KL Methods Mol Biol; 2016; 1383():105-14. PubMed ID: 26660179 [TBL] [Abstract][Full Text] [Related]